INFINITY PHARMACEUTICALS INC's ticker is INFI and the CUSIP is 45665G303. A total of 97 filers reported holding INFINITY PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.32 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $0 | – | 200 | 0.0% | 0.00% | – |
| Q1 2023 | $0 | – | 200 | -50.0% | 0.00% | – |
| Q4 2022 | $0 | – | 400 | 0.0% | 0.00% | – |
| Q3 2022 | $0 | -100.0% | 400 | -63.6% | 0.00% | – |
| Q2 2022 | $1,000 | -92.9% | 1,100 | -91.1% | 0.00% | -100.0% |
| Q1 2022 | $14,000 | -33.3% | 12,382 | +20.4% | 0.00% | 0.0% |
| Q4 2021 | $21,000 | +2000.0% | 10,282 | -12.9% | 0.00% | – |
| Q3 2021 | $1,000 | – | 11,800 | +11700.0% | 0.00% | – |
| Q4 2018 | $0 | – | 100 | 0.0% | 0.00% | – |
| Q3 2018 | $0 | – | 100 | 0.0% | 0.00% | – |
| Q2 2018 | $0 | – | 100 | 0.0% | 0.00% | – |
| Q1 2018 | $0 | – | 100 | -80.0% | 0.00% | – |
| Q4 2017 | $0 | -100.0% | 500 | -72.2% | 0.00% | – |
| Q2 2016 | $1,000 | – | 1,800 | +260.0% | 0.00% | – |
| Q1 2016 | $0 | -100.0% | 500 | -95.5% | 0.00% | -100.0% |
| Q4 2015 | $27,000 | – | 11,006 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 6,575,000 | $21,237,000 | 2.26% |
| AIGH Capital Management LLC | 1,650,256 | $5,330,000 | 1.12% |
| BVF INC/IL | 8,383,645 | $27,079,000 | 1.02% |
| GUARDIAN POINT CAPITAL, LP | 1,200,000 | $3,876,000 | 0.97% |
| Tri Locum Partners LP | 1,210,863 | $3,911,000 | 0.97% |
| Altium Capital Management LP | 972,327 | $3,141,000 | 0.87% |
| Worth Venture Partners, LLC | 387,141 | $1,250,000 | 0.61% |
| DAFNA Capital Management LLC | 459,260 | $1,483,000 | 0.35% |
| SABBY MANAGEMENT, LLC | 530,000 | $1,712,000 | 0.33% |
| KNIGHTSBRIDGE ASSET MANAGEMENT, LLC | 173,110 | $559,000 | 0.24% |